Phenonet Inc.

Phenonet Inc. is focused on amyotrophic lateral sclerosis, with clinical research centered on the functional needs of people living with mild to moderate disease. Its trial activity is directed toward outcomes relevant to motor neuron degeneration and changes in daily functioning.

• ALS functional assessment
• Motor function preservation
• Neurodegenerative disease care

The sponsor’s research interest in ALS places emphasis on clinically meaningful measures of progression and symptom impact within a neurology setting.